摘要
目的:在体外细胞水平上模拟血管内皮炎症损伤,探讨蒙花苷对血管内皮细胞炎症损伤的保护作用及其机制。方法:采用脂多糖(LPS)刺激人脐静脉内皮细胞(EA.hy926),加入不同浓度的蒙花苷处理,DAPI染色法测定EA.hy926与单核细胞(THP-1)的黏附能力,ELISA法检测细胞上清液中肿瘤坏死因子(TNF-α)和白介素-1(IL-1)水平,Western blot法检测细胞中p38、JNK、ERK1/2、p-p38、p-JNK、p-ERK1/2、核因子-κB(NF-κB)和细胞间黏附分子-1(ICAM-1)的蛋白表达。结果:蒙花苷(5、10、20mol/L)可显著抑制LPS诱导的EA.hy926与THP-1的细胞间黏附作用,减少EA.hy926分泌的炎性因子TNF-α和IL-1水平,降低细胞中JNK、ERK1/2、p-p38、p-JNK、p-ERK1/2、NF-κB和ICAM-1的蛋白表达。结论:蒙花苷可通过抑制NF-κB及其相关信号通路的活化来减少炎性黏附和炎性因子分泌,从而缓解LPS引起的血管内皮细胞炎症损伤。
Objective: To study the protective effect of buddleoside on lipopolysccharide-induced vascular endothelial cells inflammatory injury.Methods: The cytotoxicity of buddleoside in different concentrations was determined by MTT assay. DAPI staining was used to evaluate the effect of buddleoside on adhesion of EA. hy926 and THP-1. Many protein expression,such as p38,JNK,ERK1 /2,p-p38,p-JNK,p-ERK1 /2,NF-κB and ICAM-1,were detected by the Western blot analysis. ELISA method was used to measure the levels of TNF-α and IL-1. Results:Buddleoside could not influence the growth of EA. hy926 in 0. 1 ~ 20 mol / L. Buddleoside( 5,10,20 mol / L) could inhibit the adhesion of EA hy926 and THP-1 stimulated by LPS. Western blot results indicated that buddleoside treatment leaded to a decrease in JNK,ERK1 /2,p-p38,p-JNK,p-ERK1 /2,NF-κB and ICAM-1. Furthermore,ELISA results showed that buddleoside reduced LPS-stimulated TNF-α and IL-1 production in EA. hy926. Conclusion: These data support that buddleoside can ameliorate LPS-induced inflammatory injury by inhibiting the activation of NF-κB signaling pathway,as well as decrease the inflammatory adhesion and inflammatory cytokine secretion.
出处
《中药药理与临床》
CAS
CSCD
北大核心
2016年第1期29-32,共4页
Pharmacology and Clinics of Chinese Materia Medica
基金
国家自然科学基金(NO.81274123)
浙江省重点实验室项目(2012E10002)
浙江省教育厅项目(Y201431439)